Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-25-084116

Chief Strategy Officer sold 1,885 shares at $12.04 ($22,695)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Nayak Sanjay · Chief Strategy Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-08-25 Sale : show line 1 in the form 10b5-1 −1,885 $12.04 $22,695 279,738 D
Open-market sales · 1,885 sh · avg $12.04 · $22,695
Loading xslF345X05/tm2524438-3_4seq1.xml…